Allergic Bronchopulmonary Aspergillosis Clinical Trials

8 recruitingLast updated: May 13, 2026

There are 8 actively recruiting allergic bronchopulmonary aspergillosis clinical trials across 3 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Jinan, Shandong, China, Chandigarh, Chandigarh, India, Chandigarh, India. Updated daily from ClinicalTrials.gov.


Allergic Bronchopulmonary Aspergillosis Trials at a Glance

8 actively recruiting trials for allergic bronchopulmonary aspergillosis are listed on ClinicalTrialsFinder across 5 cities in 3 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Jinan, Chandigarh, and Chandigarh. Lead sponsors running allergic bronchopulmonary aspergillosis studies include Qianfoshan Hospital, Post Graduate Institute of Medical Education and Research, Chandigarh, and First Affiliated Hospital of Ningbo University.

Browse allergic bronchopulmonary aspergillosis trials by phase

Treatments under study

About Allergic Bronchopulmonary Aspergillosis Clinical Trials

Looking for clinical trials for Allergic Bronchopulmonary Aspergillosis? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Allergic Bronchopulmonary Aspergillosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Allergic Bronchopulmonary Aspergillosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA

Allergic Bronchopulmonary AspergillosisEfficacy and SafetyABPA+3 more
Qianfoshan Hospital50 enrolled1 locationNCT07362693
Recruiting

Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary AspergillosisSevere AsthmaABPA
Qianfoshan Hospital20 enrolled2 locationsNCT07530770
Recruiting
Not Applicable

Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome

Allergic Bronchopulmonary AspergillosisChronic Pulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh104 enrolled2 locationsNCT05444946
Recruiting

Immune Status and Disease Control of Inflammatory Airway Diseases

Airway inflammationChronic Obstructive Pulmonary Disease (COPD)Bronchiectasis+3 more
First Affiliated Hospital of Ningbo University200 enrolled1 locationNCT07493629
Recruiting

A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA

Airway ClearanceAllergic Bronchopulmonary AspergillosisABPA+4 more
Qianfoshan Hospital44 enrolled1 locationNCT07362667
Recruiting

Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis (ABPA)
Qianfoshan Hospital140 enrolled1 locationNCT07040332
Recruiting
Phase 2

iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine

Allergic Bronchopulmonary AspergillosisChronic Pulmonary AspergillosisPulmonary Aspergillosis
Radboud University Medical Center10 enrolled1 locationNCT06244979
Recruiting
Phase 3

A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh300 enrolled1 locationNCT06174922